Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors.

被引：0
|
作者：
Verma, SK
Reddy, S
Nagarathnam, D
Shao, JX
Zhang, L
Zhao, J
Wang, YM
Li, T
Mull, E
Wang, CG
Zhu, QM
Altieri, M
Dang, TTA
Jordan, J
机构：
[1] Bayer Pharmaceut, Dept Chem, West Haven, CT 06516 USA
[2] Bayer Pharmaceut, Dept Canc Res, West Haven, CT USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
232-MEDI
引用
收藏
页码：U949 / U949
页数：1
相关论文
共 50 条
  • [1] Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors
    Verma, S
    Nagarathnam, D
    Shao, JX
    Zhang, L
    Zhao, J
    Wang, YM
    Li, TD
    Mull, E
    Enyedy, I
    Wang, CG
    Zhu, QM
    Altieri, M
    Jordan, J
    Dang, TTA
    Reddy, S
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (08) : 1973 - 1977
  • [2] Synthesis of urea and semicarbazide analogs of indenopyrazoles as Cyclin-Dependent Kinase inhibitors.
    Vidwans, A
    Nugiel, DA
    Benfield, PA
    Burton, KRA
    Cox, S
    Grafstrom, RH
    Seitz, SP
    Trainor, GL
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U9 - U9
  • [3] Cyclin-dependent kinase inhibitors
    Westwell, A
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (09) : 491 - 491
  • [4] Cyclin-dependent kinase inhibitors
    Dai, Y
    Grant, S
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (04) : 362 - 370
  • [5] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    [J]. MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
  • [6] Thrombopoietin-induced proliferation is paralleled by expression of cyclin-dependent kinase inhibitors.
    Quentmeier, H
    Drexler, HG
    [J]. BLOOD, 1997, 90 (10) : 3456 - 3456
  • [7] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Diana M. Gitig
    Andrew Koff
    [J]. Molecular Biotechnology, 2001, 19 : 179 - 188
  • [8] Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-dependent kinase 2 inhibitors.
    Li, XY
    Huang, P
    Cui, J
    Zhang, J
    Tang, C
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U186 - U186
  • [9] Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitors.
    Gervaso, Lorenzo
    Montero, Alberto J.
    Jia, Xuefei
    Khorana, Alok A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Novel cyclin-dependent kinase inhibitors
    Westwell, AD
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (13) : 701 - 701
12345